Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

4.4K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
The Ras Gene02:38

The Ras Gene

5.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Channel Rhodopsins01:11

Channel Rhodopsins

2.5K
Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Erythropoietic EPO (EPO-R76E) Protects RPE Cells from Ferroptosis by Modulating the Labile Iron Pool and NRF2-GPX4 Axis.

Antioxidants (Basel, Switzerland)·2026
Same author

Modification of the VP1u region boosts transduction of adeno-associated virus vectors for ocular gene therapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's disease.

Brain : a journal of neurology·2026
Same author

Optimized economic scheduling of demand response in integrated energy systems considering dynamic energy efficiency and dynamic carbon trading.

Scientific reports·2026
Same author

Modulation of retinal inflammation delays degeneration in a mouse model of geographic atrophy.

Scientific reports·2025
Same author

Exposure to environmental toxicants and gout risk in adults: Unveiling the associations and potential targets.

Ecotoxicology and environmental safety·2025

Related Experiment Video

Updated: Apr 26, 2026

A Rhodopsin Transport Assay by High-Content Imaging Analysis
12:11

A Rhodopsin Transport Assay by High-Content Imaging Analysis

Published on: January 16, 2019

5.8K

Gene augmentation for adRP mutations in RHO.

Alfred S Lewin1, Brian Rossmiller1, Haoyu Mao1

  • 1Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, Florida 32610.

Cold Spring Harbor Perspectives in Medicine
|July 20, 2014
PubMed
Summary

Gene therapy for autosomal dominant retinitis pigmentosa (adRP) aims to preserve vision by targeting rhodopsin (RHO) gene mutations. Strategies like RHO augmentation and suppression show promise in preserving rod photoreceptor cells in adRP mouse models.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

6.1K
Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
14:02

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

7.9K

Related Experiment Videos

Last Updated: Apr 26, 2026

A Rhodopsin Transport Assay by High-Content Imaging Analysis
12:11

A Rhodopsin Transport Assay by High-Content Imaging Analysis

Published on: January 16, 2019

5.8K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

6.1K
Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
14:02

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

7.9K

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the rhodopsin (RHO) gene cause autosomal dominant retinitis pigmentosa (adRP), leading to photoreceptor cell death and vision loss.
  • adRP pathogenesis involves both interference with normal rhodopsin function and intrinsic toxicity of mutant rhodopsin proteins.
  • Preserving central vision by promoting rod photoreceptor survival, particularly in the macula, is a key goal for adRP gene therapy.

Purpose of the Study:

  • To investigate therapeutic strategies for autosomal dominant retinitis pigmentosa (adRP) by targeting rhodopsin (RHO) gene mutations.
  • To evaluate the efficacy of RHO augmentation and RHO suppression in preserving rod photoreceptor cells in adRP models.
  • To explore the potential of gene therapy for maintaining central vision in patients with adRP.

Main Methods:

  • Utilized adeno-associated virus (AAV) for gene delivery to the retina.
  • Developed and tested strategies for RHO gene augmentation to increase wild-type protein levels.
  • Implemented and assessed methods for suppressing rhodopsin expression, noting their non-specific nature.
  • Conducted experiments using autosomal dominant retinitis pigmentosa (adRP) mouse models.

Main Results:

  • Both RHO augmentation and a combined RHO supplementation plus suppression strategy were effective.
  • These strategies demonstrated the preservation of rod photoreceptor cell survival in adRP mouse models.
  • The study highlights the potential of gene-based interventions for adRP.

Conclusions:

  • Gene therapy approaches targeting rhodopsin (RHO) gene mutations show significant promise for treating autosomal dominant retinitis pigmentosa (adRP).
  • RHO augmentation and combined suppression strategies can preserve rod photoreceptor cells, potentially safeguarding vision in adRP patients.
  • Further research into allele-specific suppression could enhance therapeutic specificity and efficacy.